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Lothar Kanz1 and Hans-Georg Kopp1*Abstract
Background: While paraneoplastic leukocytosis is a common phenomenon in solid tumors, extreme elevations of
white blood counts (WBC) in the range of more than 100,000/μl are uncommon in patients with non-hematologic
malignancies. Leukocytosis with mature neutrophils due to a granulocyte colony-stimulating factor (G-CSF)
producing tumor is only seen on rare occasions.
Case presentation: Massive neutrophil leukocytosis of approximately 100,000/μl was diagnosed in a 57-year-old
Caucasian woman with metastatic undifferentiated endometrial sarcoma. A bone marrow trephine biopsy revealed
massively increased granulopoiesis, but no evidence of monoclonal myeloproliferative disease. After the primary
tumor had been resected, white blood count (WBC) plummeted and went back to nearly normal levels within one
week. With progressive metastatic disease, granulocyte colony-stimulating factor (G-CSF) plasma levels were found
to be increased by 10-fold. White blood count (WBC) strictly correlated with tumor burden and response to
chemotherapy. In the final stage of treatment resistent disease, white blood count (WBC) approximated 300,000/μl.
Conclusion: We report on a granulocyte colony-stimulating factor (G-CSF) secreting undifferentiated endometrial
sarcoma, which was associated with extreme neutrophil counts. White blood count (WBC) were closely correlated
with tumor burden and associated with an aggressive clinical course. We suggest that paraneoplastic neutrophilia
represents a poor prognostic sign in soft tissue sarcoma. In patients with similar constellations, antitumor therapy
must not be delayed.
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Paraneoplastic leukocytosis is a common phenomenon
in several different solid tumors. Affected patients typ-
ically have total white blood counts (WBC) between
12,000 and 30,000/μl with mainly mature neutrophil
granulocytes [1].
Idiopathic extreme leukocytosis, also known as leuke-
moid reaction and defined as WBC ≥ 40,000/μl is rare in
patients with non-hematologic malignancies: in the largest* Correspondence: hans-georg.kopp@med.uni-tuebingen.de
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reproduction in any medium, provided the orretrospective analysis of these uncommon patients, only
10% of cases were paraneoplastic in origin. Ninety-six
percent of these patients had neutrophilia, and the
mean WBC was 53,000/μl [2]. A severe left shift, i.e. the
presence of immature granulocytes such as myelocytes,
promyelocytes, and blasts suggests myeloproliferative
disorders, while paraneoplastic neutrophilia typically pre-
sents with mature neutrophils only. Leukocytosis with
non-clonally derived mature neutrophils, due to paraneo-
plastic production of granulocyte colony-stimulating
factor (G-CSF) is a rare phenomenon and has been
described in a variety of different tumors [2,3]. Mostd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Abdominal computed tomography scan with primary
tumor (14 × 10 × 12 cm) in close relation to the uterus, with
peritoneal nodules and ascites (white arrow).
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itourinary carcinomas [4-8]. G-CSF producing tumors
are typically poorly differentiated and patients are
diagnosed in an advanced stage with a large tumor
burden [9,10]. Accordingly, disease outcomes are poor,
which has been postulated to represent autocrine
stimulation of tumor growth by G-CSF [11,12]. In
this article we report on a patient with a G-CSF
producing undifferentiated endometrial sarcoma withTable 1 Differential blood counts after surgery
Parameter Day 0 Day 0 2 h
WBC (μl−1) 96.910 41.4
Neutrophils (%) 88 n.d
Hemoglobin (g/dl) 8.0 8.8
Platelets (μl−1) 298.000 59.0
C-reactive protein (mg/dl) 0.84 0.9
LDH (U/l) 260 n.d
n.d.: not determined; WBC: white blood count; LDH: lactate dehydrogenase; postopmassive neutrophil leukocytosis and an aggressive
clinical course.Case presentation
Herein, we report on a 57-year-old Caucasian woman,
who presented to our emergency department on July 30th
2011 with severe abdominal pain and a palpable lower
abdominal tumor. A computed tomography (CT) scan
revealed a 14 × 10 × 12 cm mass with close relation to
the uterus (Figure 1). Multiple pulmonary and peri-
toneal nodules consistent with metastatic disease were
seen. Blood counts revealed massive leukocytosis (WBC
96,910/μl) and anemia with a hemoglobin concentration
of 8 g/dl. A differential hemogram revealed immature
precursor cells such as promyelocytes and myelocytes
as well as pronounced neutrophilia with 88% neutro-
phils. Lactate dehydrogenase (LDH) was slightly ele-
vated (260 U/l), but the remaining laboratory values
were within normal limits (Table 1). A bone marrow
biopsy was performed at the same day. Figure 2A
shows the trephine biopsy at 400x magnification stained
with hematoxylin & eosin (H&E). Figure 2B reveals
marked hypercellularity due to granulocytic prolifera-
tion (naphthol-ASD-chloroacetate esterase stain, 400x).
Immunohistochemistry with anti-CD34 stained vascular
endothelium as positive control, but there was no
detecteable increase in CD34+ cells (Figure 2C, 200x).
Moreover, there were no signs of myelodysplasia. Cytogen-
etic and molecular analyses revealed neither translocation
t(9;22) nor a BCR/ABL fusion gene. In addition, analysis
of JAK2-V617F mutation was performed and showed a
negative result.
Simultaneously, the general condition of the patient rap-
idly worsened over night and a further hemoglobin decline
was diagnosed. Another CT scan on the following day
confirmed abdominal bleeding (white arrows, Figure 3).
An emergency operation including hysterectomy and
bilateral adnexectomy was performed. Intraoperatively,
a grossly enlarged, partly ruptured uterus with spontan-
eous intraperitoneal bleeding was found. A concurrently
causative bleeding disturbance was excluded by routinepostop. Day 3 postop. Reference values
10 15.050 4.000 – 9.000
. 84.7 40 – 80
10.0 14.0 – 18.0
00 146.000 150.000 – 450.000
5 2.35 < 0.5
. n.d. <250
.: postoperative.
Figure 2 Bone marrow trephine biopsy performed on admission. A) Hematoxylin & eosin staining, 400x magnification. B) Naphthol-ASD-
chloroacetate esterase stain, 400x magnification, showing marked hypercellularity due to granulocytic hyperproliferation (black arrows). C) Anti-CD34
immunohistochemistry reveals no detectable increase in CD34+ cells, 200x magnification.
Figure 3 Abdominal computed tomography scan (A) 12 hours
after first computed tomography scan showing diffuse
intraabdominal bleeding (white arrows). There is increase in the
free abdominal fluid and inhomogeneity of the abdominal mass.
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tiated endometrial sarcoma (FNCLCC grade 3).
Only few hours after tumor resection, leukocyte and
platelet counts decreased rapidly. Within one week, blood
counts returned to near normal levels. Figure 4 depicts
the rapid decline of WBC immediately after surgery.
Unfortunately, the first postoperative CT scan docu-
mented rapid progression of bilateral disseminated pul-
monary metastases (Figure 5). In parallel, WBC increased,
and chemotherapy with gemcitabine and docetaxel was
initiated [13]. Temporary stabilization was achievable, and
WBC correlated strictly with tumor burden, showing a
significant increase after 5 cycles of chemotherapy. At
that time, another CT scan confirmed considerable
growth of all preexisting and multiple new tumor mani-
festations. Because paraneoplastic G-CSF secretion was
suspected, G-CSF plasma levels were analyzed by enzyme
linked immunosorbent assay (ELISA, RnD Systems) and
found to be enormously increased to 1,270 pg/ml, corre-
sponding to about 10 times the upper limit of normal
(range 12,5 – 142 pg/ml). At the same day, WBC had
reached almost 200,000/μl (Figure 4). The performance
status of the patient worsened rapidly, certainly due to
the massive tumor growth with organ infiltration but
also due to a developing leukostasis syndrome. Second-
line chemotherapy with doxorubicin was initiated, but
proved to be ineffective in controlling the disease. After
2 cycles, chemotherapy was discontinued. The patient
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Figure 4 Blood counts after surgery. Note that white blood counts decreased immediately after surgery and strictly correlated with the further
course of disease (decrease after each cycle of chemotherapy, rapid increase in correlation to fulminant disease progression).
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In summary, this case demonstrates severe leukemoid
reaction with pathologic left shift caused by a G-CSF
secreting advanced undifferentiated endometrial sarcoma
imitating hematologic malignancy.
Consistent with previously reported cases of para-
neoplastic G-CSF secretion, leukemoid reaction was
closely correlated with tumor burden and associated
with an aggressive clinical course. To our knowledge,
neutrophilic leukocytosis up to 200,000/μl and a severe
left shift with massively increased G-CSF levels has
not been reported before as a paraneoplastic pheno-
menon in sarcoma. We suggest not to delay antitumorFigure 5 Computed tomography scan of the thorax after five cycles o
white arrows) corresponding to pulmonary metastasis.treatment in patients with a similar constellation, but
rather aggressively treat the underlying solid ma-
lignancy utilizing a response-inducing chemotherapy
regimen.Consent
Written informed consent was obtained from the pa-
tient herself before blood was drawn for G-CSF analysis.
The patient agreed to publication of this case report
and accompanying images. A copy of the written con-
sent is available for review by the Editor-in-Chief of this
journal.f chemotherapy showing multiple metastatic lesions (black and
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